Showing 1 - 10 of 6,392
Clinical trials play a decisive role in the drug approval processes. By completing a p-curve analysis of a newly compiled data set that consists of thousands of clinical trials, we substantiate that the occurrence of p-hacking in clinical trials is not merely hypothetical. Medical and...
Persistent link: https://www.econbiz.de/10011770352
The aim of this study was to assess the case fatality rate (CFR) of COVID-19 by performing a metaanalysis according to the air temperature and to determine if the temperature modifies the pandemic duration to the peak day for CFR of the COVID-19. A novel coronavirus spread began in December 2019...
Persistent link: https://www.econbiz.de/10012485743
Persistent link: https://www.econbiz.de/10009793799
The aim of this study was to assess the case fatality rate (CFR) of COVID-19 by performing a metaanalysis according to the air temperature and to determine if the temperature modifies the pandemic duration to the peak day for CFR of the COVID-19. A novel coronavirus spread began in December 2019...
Persistent link: https://www.econbiz.de/10014544516
Persistent link: https://www.econbiz.de/10010413143
Persistent link: https://www.econbiz.de/10011740630
Persistent link: https://www.econbiz.de/10013433211
This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...
Persistent link: https://www.econbiz.de/10015046580
When data are missing at random, the missing-data mechanism can be ignored but this assumption is not always intuitive for general patterns of missing data. In part I, we consider maximum likelihood (ML) estimation for a non-ignorable mechanism which is called almost missing at random (AMAR). We...
Persistent link: https://www.econbiz.de/10009476653